US Stock MarketDetailed Quotes

ZVRA Zevra Therapeutics

Watchlist
  • 8.760
  • +0.420+5.04%
Close Jan 2 16:00 ET
  • 8.590
  • -0.170-1.94%
Post 16:37 ET
467.57MMarket Cap-4.11P/E (TTM)

Zevra Therapeutics Key Stats

Zevra Therapeutics Q3 2024 Earnings Date

Currency:USDNov 12, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
4.86M
3.70M
-1.17M
Miss Est.
+67.97%
+27.63%
-24.01%
EPS
-0.42
-0.69
-0.27
Miss Est.
-5.33%
-130.00%
-63.82%
Strong Buy

Dec 31, 2024

Zevra Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 31.058M--
--2024/Q4-- / 8.776M--
Nov 12, 20242024/Q33.695M / 4.863M--
Aug 13, 20242024/Q24.449M / 4.358M--
May 8, 20242024/Q13.425M / 3.759M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 31.058M--
--2024/Q4-- / 8.776M--
Nov 12, 20242024/Q33.695M / 4.863M--
Aug 13, 20242024/Q24.449M / 4.358M--
May 8, 20242024/Q13.425M / 3.759M--

Unlock Free Earnings Estimates

Zevra Therapeutics Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 31, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data